EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 22-Jun-2026 15:15 ET (22-Jun-2026 19:15 GMT/UTC)

Radiation therapy enhances immune environment in brain metastases, improving treatment response

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

A new study led by researchers at The University of Texas MD Anderson Cancer Center demonstrated that pre-operative radiation therapy for brain metastases not only targets tumor cells directly but also can activate immune pathways that can make tumors more receptive to immunotherapy.

Journal: Clinical Cancer Research

St. Jude redesignated as WHO Collaborating Centre for Childhood Cancer

St. Jude Children's Research Hospital
Business Announcement

Redesignation as the only WHO Collaborating Centre dedicated to pediatric cancer demonstrates shared commitment in advancing childhood cancer care together globally

Lifestyle factors may influence prostate cancer risk in Indian men

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — June 17, 2026 — A new research paper was published in Volume 13 of Oncoscience on April 28, 2026, titled “Modifiable risk factors of prostate cancer: Insights from a hospital-based study.”

Journal: Oncoscience

U of Guelph prof discovers plant-based solution to target leukemia weakness

University of Guelph
Peer-Reviewed Publication

New University of Guelph research published in the renowned hematology publication Blood has uncovered a surprising weakness in acute myeloid leukemia (AML) that a compound in a common skincare ingredient may be able to target.

Journal: Blood
Funder: University of Guelph

Study explains how colorectal cancer cells maintain high iron levels

Michigan Medicine - University of Michigan
Peer-Reviewed Publication

Researchers from the University of Michigan Health Rogel Cancer Center have discovered a key metabolic pathway that allows colorectal cancer cells to accumulate large quantities of iron. Blocking that pathway reduced iron levels and caused the cancer cells to die.

Journal: Cell Metabolism
Funder: Crohn's and Colitis Foundation, Paradifference foundation

Protein linked to melanoma growth may suppress the body’s natural anti-tumor immune response

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY – June 17, 2026 – A new research paper was published in Volume 17 of Oncotarget on June 8, 2026, titled “DHHC3 interferes with antitumor immunity in melanoma cells.”

Journal: Oncotarget

New scenarios for photonic computing: a new era of photonic AI for medical diagnosis

Editorial Office of Opto-Electronic Journals Group
Peer-Reviewed Publication

Shenzhen University researchers, with industry partners, developed a black phosphorus-based all-fiber photonic AI platform for medical diagnosis. Built around a microfiber knot resonator, a black phosphorus and molybdenum disulfide heterostructure, and a specialized architecture, the system enables low-power, high-speed optical computing. In clinical tests, it performed well in retinal detachment and liver cancer diagnosis, matching senior radiologists while greatly improving energy efficiency and latency. The work points toward scalable, sustainable photonic AI for healthcare applications.

Journal: Opto-Electronic Advances
Funder: Guangdong Province Major Project of Fundamental and Applied Fundamental Research, National Natural Science Foundation of China, Department of Science and Technology of Guangdong Province, Department of Education of Guangdong Province, Stability Support Program for Shenzhen Higher Education Institutions, Shenzhen Science and Technology Program, Shenzhen's Key Industry R&D Project, Research Team Cultivation Program of Shenzhen University, Hangzhou Normal University, Ministry of Education Key Laboratory Open Scientific Projects Fund, China National Nuclear Corporation, "Tianchi Talent” Introduction Plan

FAP-targeted radiopharmaceutical therapy shows broad effectiveness across multiple cancers

Society of Nuclear Medicine and Molecular Imaging
Peer-Reviewed Publication

A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP)—which is highly expressed on many types of cancers—is safe and effective for patients, according to a new study published in the June issue of The Journal of Nuclear Medicine. In a study of nearly 90 patients with 21 different types of cancer, FAP-targeted radiopharmaceutical therapy achieved objective responses in approximately two-thirds of patients and disease control in more than 80 percent.

Journal: Journal of Nuclear Medicine

Colorectal cancer research is placing greater emphasis on immune cells

Medical University of Vienna
Peer-Reviewed Publication

Researchers at the Medical University of Vienna have described a mechanism in metastatic colorectal cancer that has received little attention to date: a key target of existing therapies, the so-called epidermal growth factor receptor (EGFR), is likely to affect more than just the cancer cells themselves. The study shows that EGFR also influences certain immune cells in the tumour microenvironment – and thereby helps determine how effectively the body’s own defences can combat the tumour. The findings have recently been published in the journal Cell Death & Differentiation.

Journal: Cell Death and Differentiation

Finding the right target: Personalizing treatment for an aggressive asbestos-linked cancer

University of Leicester
Reports and Proceedings

A new clinical trial, led by researchers in Leicester, is investigating a new personalised treatment for patients with a rare and aggressive form of cancer, potentially giving them more time with their loved ones.

Funder: NIHR Leicester Biomedical Research Centre

3
4
5
6
7